Clinical Trial Update: Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts [NA]

View source ↗

Summary

Clinical trial assessing induction therapy with autologous mesenchymal stem cells for kidney allografts has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Rejection

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Renal Transplant Rejection | NA | Status: COMPLETED